On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...
Regulatory troubles continue for Sun Pharma as the drug manufacturer’s Mumbai unit ... before taking any investment decisions. Advisory Alert: It has come to our attention that certain ...
Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
In two import alerts posted in late March and early April, the FDA said all of Jiangsu Shenli's piston syringes are subject to detention without physical examination. The agency first raised ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
Nimesulide, a commonly used painkiller can cause adverse reactions, as per the IPC alert. Nimesulide is a nonsteroidal anti-inflammatory drug (NSAID ... Ajanta Pharma, Cipla, Sun Pharma, Ipca ...
Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility ... taking any investment decisions. Advisory Alert: It has come to our attention that certain ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Royalty Pharma plc (Symbol: RPRX) entered into oversold territory, hitting an RSI reading of ...
To better respond to drug shortages, the agency needs additions to the “rulebook” that would give it more visibility into the complex pharmaceutical supply chain, Califf explained. As it ...
The pharmaceutical drug delivery market is a dynamic sector within the healthcare industry that focuses on the development and deployment of innovative technologies and systems to ensure the effective ...